Skip to main content

Respiratory Failure clinical trials at UCLA

2 in progress, 1 open to eligible people

Showing trials for
  • Revefenacin in Acute Respiratory Insufficiency in COPD

    open to eligible people ages 40 years and up

    RARICO is a pragmatic, randomized, controlled, double-blinded, multi-center trial evaluating the safety and feasibility of nebulized revefenacin in comparison to nebulized ipratropium in patients with COPD and acute respiratory failure requiring invasive mechanical ventilation.

    Los Angeles, California and other locations

  • Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome

    Sorry, not currently recruiting here

    The goal of this interventional study is to compare standard mechanical ventilation to a lung-stress oriented ventilation strategy in patients with Acute Respiratory Distress Syndrome (ARDS). Participants will be ventilated according to one of two different strategies. The main question the study hopes to answer is whether the personalized ventilation strategy helps improve survival.

    Los Angeles, California and other locations

Our lead scientists for Respiratory Failure research studies include .

Last updated: